Preserving Clinical Trial Integrity During the Coronavirus Pandemic

被引：148

作者：

McDermott, Mary M. ^{[1
]}

Newman, Anne B. ^{[2
]}

机构：

[1] Northwestern Univ, Feinberg Sch Med, Dept Med, 750 N Lake Shore Dr,10th Floor, Chicago, IL 60611 USA

[2] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15260 USA

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2020年 / 323卷 / 21期

关键词：

D O I：

10.1001/jama.2020.4689

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

This Viewpoint discusses ways the coronavirus pandemic is threatening clinical trial conduct and enrollment, and suggests ways to adapt, including changes to how outcomes data are collected and how interventions are delivered and monitored, to minimize trial disruption, maximize trial benefit, and ensure patient health and safety during the pandemic.

引用

页码：2135 / 2136

页数：2

共 3 条

[1]

[Anonymous], 2020, FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Pandemic Guidance for Industry, Investigators, and Institutional Review Boards

[2]

*CLINICALTRIALS, TRENDS CHARTS MAPS

[3] Effect of Structured Physical Activity on Prevention of Major Mobility Disability in Older Adults The LIFE Study Randomized Clinical Trial [J].

Pahor, Marco ;

Guralnik, Jack M. ;

Ambrosius, Walter T. ;

Blair, Steven ;

Bonds, Denise E. ;

Church, Timothy S. ;

Espeland, Mark A. ;

Fielding, Roger A. ;

Gill, Thomas M. ;

Groessl, Erik J. ;

King, Abby C. ;

Kritchevsky, Stephen B. ;

Manini, Todd M. ;

McDermott, Mary M. ;

Miller, Michael E. ;

Newman, Anne B. ;

Rejeski, W. Jack ;

Sink, Kaycee M. ;

Williamson, Jeff D. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 311 (23) :2387-2396

← 1 →